Eliot Forster
Insider Reports History
- Location
- Carmiel
- Signature
- /s/ Edward Sturchio, attorney-in-fact for Eliot Forster
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Eliot Forster:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Protalix BioTherapeutics, Inc. | Director | Common Stock | 7,500 | $12,075 | $1.61 | 03 Sep 2025 | By Trust |
| Protalix BioTherapeutics, Inc. | Director | Stock Options (Right to Buy) | 15,000 | 03 Sep 2025 | Direct | ||
| F-star Therapeutics, Inc. | PRESIDENT AND CEO, Director | Common Stock | 0 | $7.12 | 08 Mar 2023 | Direct | |
| F-star Therapeutics, Inc. | PRESIDENT AND CEO, Director | Stock Option (right to buy) | 0 | 08 Mar 2023 | Direct |
Insider Reports Filed by Eliot Forster
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IMTX | Immatics N.V. | 18 Mar 2026 | 0 | $0 | 3 | Director | 18 Mar 2026, 19:26 |
| PLX | Protalix BioTherapeutics, Inc. | 03 Sep 2025 | 2 | $0 | 4 | Director | 04 Sep 2025, 17:00 |
| PLX | Protalix BioTherapeutics, Inc. | 14 Sep 2023 | 1 | $0 | 4 | Director | 15 Sep 2023, 16:46 |
| PLX | Protalix BioTherapeutics, Inc. | 14 Sep 2023 | 0 | $0 | 3 | Director | 15 Sep 2023, 16:45 |
| /report/000089924323007669-forster-eliot-2023-03-08 | F-star Therapeutics, Inc. | 08 Mar 2023 | 5 | -$3,001,343 | 4 | PRESIDENT AND CEO, Director | 09 Mar 2023, 08:20 |
| /report/000120919122044007-forster-eliot-2022-07-29 | F-star Therapeutics, Inc. | 29 Jul 2022 | 3 | +$28,707 | 4 | President and CEO, Director | 02 Aug 2022, 21:08 |
| /report/000120919122022313-forster-eliot-2022-03-31 | F-star Therapeutics, Inc. | 31 Mar 2022 | 1 | $0 | 4 | President and CEO, Director | 04 Apr 2022, 16:07 |
| /report/000120919122002918-forster-eliot-2022-01-09 | F-star Therapeutics, Inc. | 09 Jan 2022 | 1 | $0 | 4 | President and CEO, Director | 11 Jan 2022, 16:27 |